Location

Rochester, Minnesota

Contact

babulal.ganesh@mayo.edu

SUMMARY

Ganesh M. Babulal, Ph.D., O.T.D., studies the detection of early brain changes and associated risk factors in Alzheimer's disease and related dementias using clinical evaluation, neuropsychological testing and biomarkers. Dr. Babulal's research program investigates how high-frequency, real-world behavioral signals — such as naturalistic driving, mobility, sleep, mood and social engagement — can detect functional vulnerability during preclinical stages. He also investigates whether these signals can predict cognitive decline, loss of independence and safety risks in populations of people with a variety of backgrounds.

Dr. Babulal integrates these factors to connect real-world behavior with disease biomarkers and lived contexts:

  • Longitudinal cohort designs.
  • Passive sensing and ecological momentary assessment.
  • Geospatial and environmental exposome.
  • Machine learning and artificial intelligence.

Additionally, Dr. Babulal extends this framework to organizational and social determinants of health. His work includes research on dementia risk in groups and populations with limited access to resources worldwide. Dr. Babulal also studies factors such as bilingualism and cognitive reserve that may modify vulnerability across populations.

Focus areas

  • Naturalistic driving and safety. Dr. Babulal studies driving behavior as a complex daily function that begins to decline many years before dementia symptoms are recognized. He uses in-vehicle, real-world measurement and longitudinal follow-up to model changes in driving. Dr. Babulal evaluates crash-risk-relevant behaviors and functional thresholds that may signal emerging cognitive decline and disease progression.
  • Functional precision aging models. Dr. Babulal develops translational models that integrate digital behavioral markers with Alzheimer's disease biomarkers. He also evaluates clinical characterization to predict cognitive decline and loss of independence. Dr. Babulal uses multimodal data integration and machine learning to improve early risk stratification and monitoring in aging cohorts.
  • Mood and neuropsychiatric pathways. Dr. Babulal examines depression and other neuropsychiatric symptoms as risk factors and early manifestations of dementia-related vulnerability. He studies how mood, cognition and biomarkers interact over time to shape real-world functional outcomes. These outcomes include mobility and driving behavior.
  • Social and structural determinants of health. Dr. Babulal investigates how organizational and social determinants of health contribute to health drivers in dementia risk, early detection and health outcomes. He designs studies that better represent understudied communities with a variety of backgrounds and evaluates how context and access shape functional trajectories.
  • Global health and multidimensional risk. Dr. Babulal extends research on the drivers of dementia and related health issues to global settings. His research includes dementia risk in low- and middle-income countries and studies of bilingualism and cognitive reserve. Dr. Babulal uses these programs to test whether risk and resilience mechanisms differ across cultures, languages and health systems.

Significance to patient care

People may start to lose complex skills used in everyday activities for many years before memory problems are easy to see. Some tests can miss these early changes. Dr. Babulal looks at everyday signals such as driving behavior, how people move around their communities, sleep habits and mood changes to help spot risks sooner. He also studies how these signals differ across people and communities.

Earlier clues could help patients and medical teams make earlier plans, support safety and decide who needs more testing. This research also can track whether treatments or lifestyle changes help people stay independent.

Professional highlights

  • Fellow, American Occupational Therapy Association, 2025-present.
  • Inducted member, Academy of Research, American Occupational Therapy Foundation, 2024-present.
  • Associate editor, Alzheimer's and Dementia, 2023-present.
  • Associate editor, Journal of Applied Gerontology, 2021-present.
  • Research associate, Department of Psychology, Faculty of Humanities, University of Johannesburg, South Africa, 2021-present.
  • Alzheimer's Association:
    • Committee member, Research Fellowship and Research Fellowship to Promote Diversity program, 2020-present.
    • Bill Thies Award for Distinguished Service to the International Society to Advance Alzheimer's Research and Treatment, 2026.
    • Member, International Society to Advance Alzheimer's Research and Treatment, Advisory Council, 2022-2024.
    • Council member, International Research Grant Program, 2020-2024.
    • Chair, Diversity and Disparities Professional Interest Area, International Society to Advance Alzheimer's Research and Treatment, 2020-2022.
  • Associate editor, Dementia section, BMC Neurology, 2019-present.
  • Sister Genevieve and Azela Gohl-Giese Distinguished Speaker, St. Catherine University, 2026.
  • Dean's Impact Award, Washington University School of Medicine, 2025.

PROFESSIONAL DETAILS

Administrative Appointment

  1. Senior Associate Consultant II-Research, Division of Experimental Neurology, Department of Neurology
  2. Senior Associate Consultant II-Research, Division of Computational Biology, Department of Quantitative Health Sciences

Clinical Studies

Learn about clinical trials that address specific scientific questions about human health and disease.

Explore all research studies at Mayo Clinic.

Publications

See the peer-reviewed findings I have published as a result of my research.

Review publications.
.
BIO-20602801

Mayo Clinic Footer